Non-invasive methods for iron overload evaluation in dysmetabolic patients

Author(s):Show less -

Branissoa, Paula Pessin Fabrega ; Oliveira, Claudia Pinto Marques Souza de ; Filho, Hilton Muniz Leao ; Lima, Fabiana Roberto ; Santose, Aritania Sousa ; Mancini, Marcio Correa ; de Melo, Maria Edna ; Carrilho, Flair Jose ; Rocha, Manoel de Souza ; Clark, Paul ; Branissok, Henrique Jose Pereira ; Cercato, Cintia

• Document type: Journal article
• Source: ANNALS OF HEPATOLOGY; v. 27, n. 4, p. 8-pg., 2022-05-24.

Abstract

Introduction: Although hyperferritinemia may reflect the inflammatory status of patients with non-alcoholic fatty liver disease (NAFLD), approximately 33% of hyperferritinemia cases reflect real hepatic iron overload. Aim: To evaluate a non-invasive method for assessing mild iron overload in patients with NAFLD using 3T magnetic resonance imaging (MRI) relaxometry, serum hepcidin, and the expression of ferritin subunits. Methods: This cross-sectional study assessed patients with biopsy-proven NAFLD. MRI relaxometry was performed using a 3T scanner in all patients, and the results were compared with iron content determined by liver biopsy. Ferritin, hepcidin, and ferritin subunits were assessed and classified according to ferritin levels and to siderosis identified by liver biopsy. Results: A total of 67 patients with NAFLD were included in the study. MRI revealed mild iron overload in all patients (sensitivity, 73.5%; specificity, 70%). For mild (grade 1) siderosis, the transverse relaxation rate (R2*) threshold was 58.9 s-1 and the mean value was 72.5 s-1 (SD, 33.9), while for grades 2/3 it was 88.2 s-1 (SD, 31.9) (p < 0.001). The hepcidin threshold for siderosis was > 30.2 ng/mL (sensitivity, 87%; specificity, 82%). Ferritin H and ferritin L subunits were expressed similarly in patients with NAFLD, regardless of siderosis. There were no significant differences in laboratory test results between the groups, including glucose parameters and liver function tests. Conclusions: MRI relaxometry and serum hepcidin accurately assessed mild iron overload in patients with dysmetabolic iron overload syndrome.(c) 2022 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) (AU)

• FAPESP's process: 15/13524-3 - Iron overload evaluation by non invasive methods in overweight patients with hyperferritinemia
• Grantee: Cintia Cercato
• Support Opportunities: Regular Research Grants